New SAGA Colorectal Cancer Diagnostic Helps Predict Recurrence

 
• By Elizabeth Orr
  
SAGA Diagnostic's Pathlight can detect lower levels of colorectal cancer biomarkers than other molecular diagnostics. (Antonio Marco/Shutterstock)

More from In Vitro Diagnostics

More from Medtech Insight